Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
03/2005
03/16/2005EP1514934A2 Biosynthetic binding protein for cancer marker
03/16/2005EP1514932A2 Glucagon receptors
03/16/2005EP1514931A1 Immunosuppressant target proteins
03/16/2005EP1514928A1 Method of constructing antibody
03/16/2005EP1514876A2 Antibody against prostate stem cell antigen (PSCA)
03/16/2005EP1514561A1 Targeting of tumor vasculature using radiolabelled antibody L19 against fibronectin ED-B
03/16/2005EP1514558A1 Use of MARKK or MARKK antagonists for the treatment of pathologies characterised by increased or reduced phosphorylation of MARK or tau protein
03/16/2005EP1514216A2 Generation and selection of protein library in silico
03/16/2005EP1514104A1 Proteins with repetitive bacterial-ig-like (big) domains present in leptospira species
03/16/2005EP1513955A2 Diagnostic and therapeutic use of cyp11a1 for neurodegenerative diseases
03/16/2005EP1513937A2 A method for the stimultaneaous production of multiple proteins; vectors and cells for use therein
03/16/2005EP1513879A2 Synthetic antibody phage libraries
03/16/2005EP1513878A2 Compositions and methods for apo-b48 and apo-b100 assay
03/16/2005EP1513867A2 Extracellular junctional adhesion molecules
03/16/2005EP1513864A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
03/16/2005EP1513860A2 P450 enzymes, nucleic acids encoding them and methods of making and using them
03/16/2005EP1513554A1 Cd16a binding proteins and use for the treatment of immune disorders
03/16/2005EP1513553A1 Methods and materials for treating inflammatory conditions
03/16/2005EP1456241B1 Mono-and dual anti-cd4-rantes chemokine/cytokine constructs
03/16/2005EP1390741A4 Structure-based construction of human antibody library
03/16/2005EP1343880A4 Expression of xenogenous (human) immunoglobulins in cloned, transgenic ungulates
03/16/2005EP1268784B1 Genes involved in intestinal inflammatory diseases and use thereof
03/16/2005EP1204423B1 Therapeutic antibody against muc-1 antigen and methods for their use
03/16/2005EP1165134B1 Use of anti-ferritin monoclonal antibodies in the treatment of some cancers
03/16/2005EP1024826B1 Passive immunization against clostridium difficile disease
03/16/2005EP0948609B1 Llg polypeptides of the triacylglycerol lipase family, and compositions and methods for their use in enzymatic hydrolysis, and protein and gene therapies
03/16/2005EP0721783B1 Preventive and remedy for diseases caused by fibrinoid or thrombus formation in the lung
03/16/2005CN1596371A Novel self-assembly molecules
03/16/2005CN1596313A Humanized collagen antibodies and related methods
03/16/2005CN1596269A A novel G protein-coupled receptor, gave 10
03/16/2005CN1596266A Specific binding agents of human angiopoietin-2
03/16/2005CN1594363A Anti-human phylaxin synthetic polypeptide antibody and its preparation method
03/16/2005CN1594362A Yolk antibody specific for helicobacter pylori and its preparation and application
03/16/2005CN1594361A Human source anti- tetanus exotoxin antibody and preparation method and use thereof
03/16/2005CN1193094C Antigenic proteins of shrimp white spot syndrome virus and uses thereof
03/16/2005CN1193041C New human protein with the function of inhibiting cancer cell growth and its encoding sequence
03/16/2005CN1193040C New human protein with the function of inhibiting tumor cell growth and its encoding sequence
03/16/2005CN1192796C Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies
03/15/2005US6867292 Characterization of novel gene cbl-SL
03/15/2005US6867288 Polycystic kidney disease gene
03/15/2005US6867187 Composition and method for modulating somatolactogenic function
03/15/2005US6867041 Simultaneous stimulation and concentration of cells
03/15/2005US6867016 Reagents and methods useful for detecting diseases of the gastrointestinal tract
03/15/2005US6867013 Methods of screening for antagonists and agonists of polypeptides having kinase functions
03/15/2005US6866850 Prevention and treatment of amyloidogenic disease
03/15/2005US6866849 Administering an A beta peptide to induce immune response; monitoring and detecting antibodies having A beta binding specificity; Alzheimer*s disease
03/15/2005US6866848 Diagnosis and therapy of immune disorders induced by inhibitors of blood-coagulation factor VIII and inhibitors to binding of von Willebrand factor and/or membrane phosphatides
03/15/2005US6866845 Administering anti-C5a antibodies to treat blood and toxin disorders
03/15/2005CA2170034C Recombinant humanized anti-human immunodeficiency virus antibody
03/15/2005CA2124964C Cdw52-specific antibody for treatment of multiple sclerosis
03/10/2005WO2005022160A2 Diagnosis and treatment of micobacterial infections
03/10/2005WO2005021792A1 Preventive or remedy for inflammatory bowel diseases containing anti-cd81 antibody as the active ingredient
03/10/2005WO2005021758A1 Recombinant polypeptide useful for neurotrophin receptor mediated gene delivery and as neurotrophin agonist
03/10/2005WO2005021739A1 ANTIBODY AGAINST Nox1 POLYPEPTIDE, METHOD OF DIAGNOSING CANCER WITH THE USE OF Nox1 GENE AND METHOD OF SCREENING CANCER GROWTH INHIBITOR
03/10/2005WO2005021734A2 Generation of hematopoietic chimerism and induction of central tolerance
03/10/2005WO2005021728A2 Enriched pancreatic stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for these populations
03/10/2005WO2005021713A2 Vectors expressing sars immunogens, compositions containing such vectors or expression products thereof, methods and assays for making and using
03/10/2005WO2005021711A2 Approach for obtaining monoclonal antibodies to cell surface proteins
03/10/2005WO2005021710A2 Chimeric molecules and methods of use
03/10/2005WO2005021709A2 Cln101 antibodies
03/10/2005WO2005021595A1 Methods of antibody engineering using antibody display rules
03/10/2005WO2005021594A2 Minimally immunogenic variants of sdr-grafted humanized antibody cc49 and their use
03/10/2005WO2005021576A2 Methods for for modeling gpcrs and for producing ligand blocking and receptor activating antibodies for same
03/10/2005WO2005021462A1 Method for the production of porous carbon-based molded bodies, and use thereof as cell culture carrier systems and culture systems
03/10/2005WO2005021036A1 Multiconstituent liquid igg and igm calibrators
03/10/2005WO2005020927A2 Method of promoting graft survival with anti-tissue factor antibodies
03/10/2005WO2005020924A2 A rapid way to obtain high expression clones of mammalian cells using a methylcellulose and immunoprecipitation screening method
03/10/2005WO2005020919A2 Method of treatment and bioassay involving macrophage migration inhibitory factor (mif) as cardiac-derived myocardial depressant factor
03/10/2005WO2005020891A2 Monoclonal antibodies against ricin toxin and methods of making and using thereof
03/10/2005WO2005020799A2 METHOD FOR MEASURING FCϵRII/CD23 IGE RECEPTOR IN HUMAN FECES AS AN INDICATOR OF A TH2 PREDOMINANT IMMUNE RESPONSE INVOLVED IN GASTROINTESTINAL ILLNESSES
03/10/2005WO2005020785A2 Discovery of the microorganism that causes the human autoimmune disease, primary biliary cirrhosis
03/10/2005WO2005003172A3 Pan-kir2dl nk-receptor antibodies and their use in diagnostik and therapy
03/10/2005WO2005003170A3 Modified antibody fragments
03/10/2005WO2004081027A3 Neoplasm specific antibodies and uses thereof
03/10/2005WO2004078907A3 Streptococcus pyogenes antigens
03/10/2005WO2004075723A3 Methods for the early diagnosis of ovarian cancer
03/10/2005WO2004073393A8 Immunogene adherence and method of making and using same
03/10/2005WO2004058190A3 Methods for treating taxol-induced sensory neuropathy
03/10/2005WO2004048411A3 Compounds and methods for modulating desmosomal and atypical cadherin-mediated cell adhesion
03/10/2005WO2004035742A3 Sets of digital antibodies directed against short epitopes, and methods using same
03/10/2005WO2004003166A3 Antibodies and uses thereof
03/10/2005WO2003085089A3 Human monoclonal antibodies to interleukin-5 and methods and compositions comprising same
03/10/2005WO2003076570A3 Antigens and their use as diagnostics and vaccines against species of plasmodium
03/10/2005WO2003065003A3 Nuclear matrix protein alterations associated with colon cancer and colon metastasis to the liver, and uses thereof
03/10/2005US20050055735 Use of complement protein C3 and its derivatives in enhancing mammalian embryo development
03/10/2005US20050054835 Immunoglobulin fusion comprising gelonin and shiga-like toxin for use in treatment and prevention of graft vs host, autoimmue and cell proliferative disorders
03/10/2005US20050054834 Using immunoaffinity matrix to isolate immunoglobulin angiogenesis inhibitors for use in treatment of vision, inflammatory and cell proliferative disorders
03/10/2005US20050054833 Immunoglobulin fusion for use in treatment and prevention of asthma, food allergies, sinus inflammation and vision defects
03/10/2005US20050054832 Optimized Fc variants and methods for their generation
03/10/2005US20050054828 Proteins involved in cytoadhesion of plasmodlum falciparum ring-stage-infected erythrocytes, antibodies which bind to the proteins, and methods for detecting infection, stage of infection and vaccines for protecting against infection
03/10/2005US20050054827 Conotoxin amino acid sequences for use as tool in controlling pain; immunotherapy; mimetics
03/10/2005US20050054825 Osteogenic devices
03/10/2005US20050054823 Genes
03/10/2005US20050054593 New drug
03/10/2005US20050054592 Alzheimer's disease; Parkinson's disease; isolated nucleic acids
03/10/2005US20050054576 Non-mammalian GnRH analogs and uses thereof in regulation of fertility and pregnancy
03/10/2005US20050054575 Peptide agonists of prostate-specific antigen and uses therefor
03/10/2005US20050054568 Angiogenesis-modulating compositions and uses
03/10/2005US20050054564 Proteins for use in treatment of gastrointestinal disorders; novel gene product designated Antrum Mucosal Protein 18 ("AMP-18") is a gastrokine
03/10/2005US20050054057 Preparing immunoglobulin which specifically bind sulfonylated glyceraldehyde dehydrogenase (GAPDH) and peroxiredoxins (Prxs) for use as diagnostic tool in detection of free radical damage in cells
1 ... 761 762 763 764 765 766 767 768 769 770 771 772 773 774 775 776 777 778 779 780 781 ... 1494